The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the International Health Regulations (2005) (IHR) Emergency Committee (Committee) ...

The Director-General of the World Health Organization (WHO) is hereby transmitting the report of the fourth meeting of the ...

In August 2024, the World Health Organization declared a second "Public Health Emergency of International Concern" for mpox.

NanoViricides, Inc., a publicly traded company (NYSE Amer.:NNVC) (the “Company”), and a clinical stage, leading global pioneer in the development of broad-spectrum antivirals based on host-mimetic ...

LEN is the first long-acting PrEP product that requires only two injections per year, offering an appealing alternative to ...

Africa has recorded more than 4,200 deaths due to ongoing cholera and mpox outbreaks in different parts of the continent in ...

As part of its continued support to Sierra Leone’s health sector, the World Health Organization (WHO) has donated essential ...

The World Health Organization (WHO) has renewed its declaration that Mpox (formerly monkeypox) remains a Public Health Emergency of International Concern (PHEIC). WHO Director-General Dr. Tedros ...

Cholera and mpox outbreaks have killed 4,200 people in different parts of Africa, the Africa Centers for Disease Control and ...

The Dangerous Drugs Board (DDB) has temporarily authorized the use of ordinary prescriptions in prescribing dangerous drugs ...

Africa has recorded more than 4,200 deaths due to ongoing cholera and mpox outbreaks in different parts of the continent in 2025, the Africa Centers for Disease Control and Prevention (Africa CDC) has ...